Sigmak Lifesciences supplies WHO-GMP sourced injectable formulations, pharmaceutical APIs, and specialty intermediates to manufacturers, importers, and distributors in Morocco. Morocco's pharmaceutical sector is one of the most developed in the Arab and African world, governed by the Direction du Médicament et de la Pharmacie (DPMED) within the Ministry of Health.
The injectable range covers antibiotics, anti-infectives, analgesics, cardiovascular agents, vitamins, and hormonal formulations across vial, ampoule, and dry powder formats. Documentation support is available in English and French, including COA, COPP, stability data, and CTD dossiers compatible with DPMED submission standards.
Morocco also serves as a regional hub for Francophone Sub-Saharan Africa. Sigmak supports customers who require supply programs structured for onward distribution and registration across the wider region.